Interviews from EBCC-6
ecancermedicalscience’s ecancertv talks to the conference president, incoming head of EACR, UK National Director and other key opinion leaders and leading researchers:
Prof. Emiel Rutgers: of the Netherlands Cancer Institute and EBCC 6 Conference Chair : Conference highlights and future of breast cancer care including freezing tumours and MRI scans for all.
Prof. Mike Richards: National Cancer Director, Department of Health, UK: Cancer spend in the UK.
EBCC-6 Roundup: Overview of the most successful European Breast Cancer Conference yet.
Dr Sibylle Loibl from the German Breast Group, discusses her research on chemotherapy for pregnant breast cancer patients and gives advice to doctors based on the findings.
David Martinez-Cecilia from the General Surgery Service, Spain, discusses the benefits of pre-op MRI scans for all breast cancer patients.
Dr Elisabetta Rapiti of the Geneva Cancer Registry, Switzerland discusses her findings on breast cancer and obesity and suggests new strategies are needed to deal with the problems, such as improved surveillance.
Prof. Mitch Dowsett: Head of Department of Biochemistry, Institute of Cancer Research, Royal Marsden, UK : Improving breast cancer care using biomarker tests.
Prof. Anne-Lise Børresen-Dale: President of European Association of Cancer Research (EACR) : Epigenetics and breast.
Prof. Aaron Goldhirsch: Director of The Department of Medicine, IEO, Milan: Large scale breast cancer trials held at the European Institute of Oncology.
Dr. Angel Rodriguez: Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston: Findings on Lapatinib's role in tackling cancer stem cells.
Dimitry Nuyten: Department of Radiation Oncology and Diagnostic Oncology, Netherlands Cancer Institute: Gene expression arrays for determining breast cancer treatment.
Giovanne Gatti: Scientific Supervisor for Umberto Veronesi Foundation (FUV): The role of FUV in the dissemination of cancer science.
Prof. Gunter von Minckwitz: Chairman of the German Breast Group: The large scale 'Quattro' study for capecitabine and docetaxel combo for early breast cancer.
Mrs Jill Hervik: Physiotherapist and Acupuncturist, Vestfold Central Hospital, Norway: Acupuncture as treatment for hot flushes in patients using anti-oestrogen medication.
Prof. Julie Gralow: Medical Oncology at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center: Strong points from the conference
Prof. Michael Untch: University of Munich and Breast Cancer Centre: Trastuzumab with chemo before surgery for women with HER2 positive tumours
Dr Alain Monnier: a medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard: No link between aromatase inhibitors and cardiovascular problems
Professor Per Lønning: Medical Oncologist, University of Bergen: Variations in treatment with Aromatase Inhibitors letrozole, anastrozole, and exemustane
Prof. Romano Danesi: of Internal Medicine, University of Pisa: Epigenetics in cancer care and predicting response to tamoxifen
Susan Knox: Executive Director of Europa Donna: The importance of EBCC and patient advocacy groups.
Page last modified: 22 Jul 2008